COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt/β-catenin signaling pathway
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Xing Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, Beijing 100034, China; Institution of Urology, Peking University, Beijing 100034, China; Nat…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Wnt Signaling Pathway, Kidney Neoplasms, Collagen Type I. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: To investigate COL1A1 expression, prognostic significance, functional roles, and underlying mechanisms in clear cell renal cell carcinoma (ccRCC). METHODS: COL1A1 expression was analyzed using public databases, Western blotting, and immunohistochemistry (IHC). Functional effects were evaluated through both loss-of-function and gain-of-function assays in vitro. An in vivo xenograft model was used to assess tumor growth and confirm epithelial-mesenchymal transition (EMT) marker changes by IHC. Mechanistic investigations involved dual-rescue experiments with a Wnt/β-catenin activator and inhibitor, and functional location assays using a secretion inhibitor and recombinant protein. RESULTS: COL1A1 was significantly upregulated in ccRCC, and high expression independently predicted poor prognosis. Bidirectional perturbations supported an oncogenic role: knockdown inhibited, whereas overexpression enhanced, cell proliferation, migration, invasion, and EMT. In vivo, COL1A1 knockdown suppressed tumor growth and histologically reversed EMT. Mechanistically, functional location studies demonstrated that COL1A1 acts predominantly from the extracellular space to activate Wnt/β-catenin signaling. This dependency was corroborated by dual-rescue experiments, in which pathway activation restored the knockdown phenotype, whereas β-catenin inhibition abrogated the effects of COL1A1 overexpression. CONCLUSION: COL1A1 is a key oncogene in ccRCC, promoting progression by activating the Wnt/β-catenin axis. COL1A1 holds potential as a prognostic biomarker and therapeutic target for ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Peking University First Hospital, Beijing 100034, China; Institution of Urology, Peking University, Beijing 100034, China; National Urological Cancer Center, Beijing 100034, China; Beijing Key Lab…
- Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China. Electronic address: zhangqianbjmu@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ji, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2026). COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt/β-catenin signaling pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112259
Vancouver
Ji X, Yun Y, Zhu Z, Wu T, Ruan M, Fan Y, et al. COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt/β-catenin signaling pathway. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112259
BibTeX
@article{Ji2026,
author = {Ji, Xing and Yun, Yongyang and Zhu, Zhenpeng and Wu, Tianyu and Ruan, Mingjian and Fan, Yu and Zhang, Qian},
title = {COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt/β-catenin signaling pathway},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112259}
}
EUVIMED